sirolimus / Generic mfg.  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

59 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sirolimus / Generic mfg.
NCT01049633: B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure

No Longer Available
N/A
US
Allogeneic Pancreatic Islet Cells, Sirolimus, Basiliximab, Tacrolimus, Antibacterial, Antifungal, and Antiviral Prophylaxis, Trimethoprim/sulfamethoxazole, Septra SS, Clotrimazole, Mycelex Troche, Valganciclovir, Valcyte, Heparin, Anticoagulation and Hematological Agent, Enoxaparin, Lovenox; Anticoagulation and Hematological Agent, Pentoxifylline, Aspirin, ASA
National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type 1 Diabetes Mellitus
 
 
ChiCTR-ONC-13003469: The effect of Rapamycin on vaginal adenosis

Completed
N/A
15
 
Rapamycin for external application
Peking Union Medical College Hospital; Peking Union Medical College Hospital, Pfizer Pharmaceuticals Ltd, USA
Vaginal adenosis
 
 
NCT06409507: Research and Application for New Clinical Diagnosis and Treatment System for HBV Related HCC Liver Transplantation

Completed
N/A
178
NA
FKBP12 expression, sirolimus
First People's Hospital of Hangzhou
Hepatocellular Carcinoma, Liver Transplantation, Prognosis
01/21
08/23
NCT01309022: Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)

No Longer Available
N/A
US
Sirolimus, Rapamune®, Tacrolimus, Prograf®, Mycophenolate mofetil, MMF, CellCept, Mycophenolic acid, Myfortic®
National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN)
Diabetes Mellitus, Type 1
 
 
ChiCTR-OOB-14005683: Metabolic changes in plasma of TSC patients treated with rapamycin using gas chromatography mass spectrometry

Recruiting
N/A
30
 
mTOR inhibitors
Chinese PLA General Hospital; Chinese PLA General Hospital, Beijing Municipal Science and Technology Committee; The National Basic Research Program of China (973 Program)
Tuberous Sclerosis Complex
 
 
ChiCTR-IPR-16009305: a Preliminary Study on the Use of Rapamycin in Refractory Graves Hyperthyroidism and Ophthalmopathy

Not yet recruiting
N/A
171
 
Antithyroid drug monotherapy ;Rapamycin monotherapy ;Rapamycin combined with antithyroid drug treatment
First Affiliated Hospital of Xi'an Jiaotong University; First Affiliated Hospital of Xi'an Jiaotong University, National Scientific Foundation Grand
Retractable Graves Disease and Ophthalmopathy
 
 
ChiCTR-OCC-15006722: Clinical trial of sirolimus in treatment of refractory vascular malformations.

Not yet recruiting
N/A
50
 
Use sirolimus for treatment
Children‘s Hospital of Fudan University; Children’s Hospital of Fudan Universiy, Children's Hospital of Fudan University
refractory vascular malformations
 
 
ChiCTR-OOB-17014129: the imbalance of mTOR mediated autophagy in septic cardiomyopathy and its therapeutic potential

Recruiting
N/A
120
 
rapamycin ;bafilomycin
Peiking Union Medical College Hospital; PUMCH, Beijing Natural Science Foundation Project
Sepsis induced cardiomyopathy
 
 
ChiCTR-INR-17012212: Use of sirolimus in patients with primary idiopathic membranous nephropathy: a prospective randomized control trial

Recruiting
N/A
70
 
Cyclosporine ;cyclosporine combined with sirolimus
Renal Division, Peking University First Hospital; Renal Division, Peking University First Hospital, Huabei Pharmaceutical Company.
idiopathic membranous nephropathy
 
 
ChiCTR-ONC-17012126: A multicenter, prospective, one-arm clinical study of Sirolimus treats refractory and recurrence primary immune thrombocytopenia

Not yet recruiting
N/A
103
 
Sirolimus treats refractory or recurrence primary immune thrombocytopenia
Department of Hematology, Xiniao Hospital; Department of Hematology, Xiniao Hospital Department of Hematology, Xiniao Hospital, Clinical Founding of Xinqiao Hospital
refractory or recurrence primary immune thrombocytopenia
 
 
ChiCTR1900023476: Multicenter, prospective and open clinical study for rapamycin in the treatment of autoimmune hemolytic anemia

Not yet recruiting
N/A
80
 
glucocorticoid ;glucocorticoid & Ciclosporin ;glucocorticoid & rapamycin ;rapamycin
Tianjin Medical University General Hospital; Tianjin Medical University General Hospital, Clinical Founding
Autoimmune
 
 
NCT02675153: To Evaluate the Efficacy and Safety of Rapamycin for Crohn's Disease-related Stricture

Recruiting
N/A
15
RoW
Rapamycin, Sirolimus
The Second Hospital of Nanjing Medical University
Crohn's Diseases
10/20
10/20
ChiCTR1900027957: Efficacy and safety of multitarget therapy with cyclophosphamide and sirolimus for lupus nephritis: a single-arm, single-center pilot study

Recruiting
N/A
20
 
cyclophosphamide and sirolimus
The First Affiliated Hospital of China Medical University; The First Affiliated Hospital of China Medical Universit, None
lupus nephritis
 
 
NCT06225206: Analysis of Donor-derived Cell Free DNA in Liver Transplant Patients

Recruiting
N/A
300
US
donor-derived cell free DNA in liver
Methodist Health System
Liver Transplant Failure
12/24
12/24
MERIT, ChiCTR2000039839: The role of mTOR gene promoter polymorphism and methylation in the development of incomplete stent endothelialization and restenosis after implantation of sirolimus ramification-coated stent

Recruiting
N/A
305
 
Rapamycin stent implantation
Zhoupu Hospital of New Pudong District in Shanghai City; Zhoupu Hospital of New Pudong District in Shanghai City, Key discipline group of New Pudong District
Coronary heart disease
 
 
NCT06196996: Allogeneic Regenerative Islet Transplantation for the Treatment of Brittle Type 1 Diabetes Mellitus

Recruiting
N/A
18
RoW
The method of islet transplantation is through percutaneous transhepatic portal vein puncture.
Shanghai Changzheng Hospital
Brittle Type 1 Diabetes Mellitus
12/25
09/26
ChiCTR2000030370: The efficacy and safety of sirolimus for the treatment of Systemic Sclerosis: a single-arm, single-center pilot study

Recruiting
N/A
20
 
sirolimus
The First Affiliated Hospital of China Medical University; The First Affiliated Hospital of China Medical University, Self-raised
Systemic Sclerosis
 
 
ChiCTR2000040947: The safety and effectiveness of rapamycin (sirolimus) in the treatment of Prader-Willi syndrome

Recruiting
N/A
30
 
rapamycin 1mg qd po
Peking Union Medical College Hospital; Peking Union Medical College Hospital, North China Pharmaceutical Company Ltd.
Prader-Willi syndrome
 
 
NCT06338306: Tacrolimus and Personalized Therapy to Prevent Acute Rejection Episodes

Recruiting
N/A
25
Europe
Tacrolimus(FK506)
Fondazione IRCCS Policlinico San Matteo di Pavia
Heart Transplant Failure
06/22
06/25
EVALU8, NCT03842813: Safety and Performance Assessment of Drug-Eluting Stent CRE8 in Diabetic Patients

Active, not recruiting
N/A
1030
Europe
DES-CRE8
Alvimedica Medical Technologies France, EVAMED
Diabetes, Coronaropathy
02/22
07/22
ChiCTR2000032184: Study on the treatment of autism spectrum disorders in children with mTOR inhibitor rapamycin

Not yet recruiting
N/A
10
 
Rapamycin
The First Medical Center of PLA General Hospital; The First Medical Center of PLA General Hospital, self-finance
Autism Spectrum Disorder
 
 
NCT00619528: HLA-Identical Sibling Renal Transplant Tolerance

Active, not recruiting
N/A
230
US
Infusion of Donor Hematopoietic Stem Cells and Campath-1H
Northwestern University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Immunosuppression, Kidney Transplantation, Graft Rejection
07/22
06/23
ChiCTR2000035480: The efficacy of sirolimus in different genotypes of low-flow vascular malformations

Not yet recruiting
N/A
108
 
Oral sirolimus treatment
Ninth People's Hospital, Shanghai JiaoTong University School of Medicine; Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Self-rised
Low-flow vascular malformation
 
 
ChiCTR2000036637: The efficacy and outcome of sirolimus in different genotypes of low-flow vascular malformations

Not yet recruiting
N/A
108
 
Nil
Ninth People's Hospital, Shanghai JiaoTong University School of Medicine; The Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shenkang
Low-flow Vascular Malformation
 
 
ChiCTR2000029921: Sirolimus combined with calcineurin inhibitors for steroid-ineffective/dependent cGVHD: multicenter, single-arm study

Not yet recruiting
N/A
78
 
given sirolimus capsules combined with ciclosporin(CsA) or tacrolimus(FK506) capsules
The Hematology Department of Xinqiao Hospital, the Second Affiliated Hospital of The Army Medical University; Level of the institution:, Army medical university clinical innovation training program
Steroid- ineffective/dependent cGVHD
 
 
Safety and efficacy of rapamycin in the treatment of PROS, ChiCTR2100042574: Safety and efficacy of rapamycin (Sirolimus) in the treatment of PI3K-AKT1-mTOR related overgrowth syndrome

Recruiting
N/A
35
 
use rapamycin
Beijing Jishuitan Hospital; Beijing Jishuitan Hospital, 2016YFC0901500
PIK3CA related overgrowth syndrome
 
 
BIOSTEMI ES, NCT05484310: BIOSTEMI Extended Survival

Completed
N/A
1300
Europe
University Hospital, Geneva, Insel Gruppe AG, University Hospital Bern
Coronary Artery Disease, Acute Coronary Syndrome
04/23
10/23
NCT06550271: The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals

Completed
N/A
67
US
Rapamycin, Sirolimus, Rapamune, Rapacan, Siromus, Raparen, Rapasim, Sirova
AgelessRx
Aging
12/23
12/23
NCT05294822: Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes

Recruiting
N/A
20
RoW
Autologous regenerative islet transplantation for insulin-dependent diabetes mellitus
Shanghai Changzheng Hospital
Diabetes
06/23
12/23
ChiCTR2200056438: Efficacy and safety of rapamycin in spinocerebellar ataxia

Not yet recruiting
N/A
35
 
rapamycin
The First People’s Hospital of Yichang, Yichang, China; The First People’s Hospital of Yichang, Yichang, China, Self-funded
spinocerebellar ataxia
 
 
MIDAS, NCT02432560: Safety and Durability of Sirolimus for Treatment of LAM

Recruiting
N/A
600
US
Sirolimus, Rapamune, rapamycin, Everolimus, Afinitor
University of Cincinnati, Rare Diseases Clinical Research Network, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), The LAM Foundation
Lymphangioleiomyomatosis
07/24
07/25
NCT01850108: Non-Myeloablative Conditioning and Bone Marrow Transplantation

Active, not recruiting
N/A
26
Europe, US
Thymoglobulin, Fludarabine, Fludara®, Cyclophosphamide (CTX), Cytoxan, Mesna, Sirolimus, rapamycin, Rapamune®, Mycophenolate mofetil (MMF), Bone marrow transplantation, Total body irradiation
Vanderbilt-Ingram Cancer Center
Sickle Cell Disease, Hemoglobinopathies
11/23
12/24
NCT00001247: Inpatient Evaluation of Adults With Schizophrenia

Recruiting
N/A
700
US
Sirolimus
National Institute of Mental Health (NIMH)
Schizophrenia
 
 
NCT04280029: SELUTION SLR™ 014 In-stent Restenosis

Active, not recruiting
N/A
418
Europe, Canada, US, RoW
SELUTION SLR™ DEB, Control
M.A. Med Alliance S.A., Iqvia Pty Ltd, Cordis Corporation
Coronary Restenosis
07/25
08/29
NCT06160739: Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations

Recruiting
N/A
10
RoW
Sirolimus 1Mg Oral Tablet
Sohag University
Microcystic Lymphatic Malformation, Combined Vascular Malformation, Vascular Malformations
09/24
09/24
ChiCTR2000040419: Clinical study of sirolimus combined with chemotherapy in the treatment of recurrent/refractory yolk sac tumor in children

Not yet recruiting
N/A
32
 
Sirolimus +TIC chemotherapy regimen
Shandong Cancer Hospital and Institute; Shandong Cancer Hospital and Institute, Clinical incubation Program of Shandong Cancer Hospital and Institute
Yolk sac tumor
 
 
NCT05233722: mTOR as Mediator of Insulin Sensitivity Study

Recruiting
N/A
10
Europe
Exercise, Insulin infusion, Placebo, Rapamycin
University of Copenhagen, Danish Diabetes Academy
Insulin Sensitivity
06/29
06/29
ME/CFS, NCT06257420: Rapamycin in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Enrolling by invitation
N/A
100
US
Rapamycin, Sirolimus, Rapamune
Simmaron Research Inc., Center For Complex Diseases-Seattle, WA, Sierra Internal Medicine, Incline Village, NV, Center for Complex Diseases- Palo Alto, CA, Simmaron Research Inc. R&D Lab, University of Wisconsin, Milwaukee (UWM), Bateman Horne Center, Salt Lake City, UT
Myalgic Encephalomyelitis
12/25
06/26
ChiCTR1900023865: Kasabach - Merritt phenomenon optimization treatment clinical research program

Recruiting
N/A
120
 
Corticosteroid ;rapamycin ;hormone in combination with propranolol ;rapamycin in combination with propranolol ;hormone in combination with vincristine ;Rapamycin in combination with hormones
Beijing Children's Hospital Affiliated to Capital Medical University; Anhui Children's Hospital, self-financing
Kaposi form hemangio endothelioma
 
 
NCT06340373: Clinical and Angiographic Outcomes of Post-drug-coated Balloon Angioplasty in Native Coronary Lesions

Recruiting
N/A
303
RoW
DCB Angioplasty
National Institute of Cardiovascular Diseases, Bangladesh
Coronary Artery Disease
12/24
06/25
NCT05450042: Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation

Recruiting
N/A
70
Europe
SELUTION SLR DCB, Paclitaxel DCB
University Hospital, Essen
Peripheral Arterial Disease, Flow-mediated Dilation, Drug Eluting Balloon, Infrainguinal Peripheral Arterial Disease
04/24
04/24
ChiCTR2000031984: Sirolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex and Epilepsy

Not yet recruiting
N/A
62
 
Antiepileptic drug + sirolimus ;antiepileptic drugs
West China Hospital, Sichuan University; West China Hospital, Sichuan University, SCI funds for West China Hospital of Sichuan University
Tuberous sclerosis complex; Epilepsy
 
 
PRE-TREG, NCT04661254: Treg Cell Therapy in Liver and Kidney Transplantation - Preclinical Validation of Batches of Treg Cells Amplified in Vitro

Not yet recruiting
N/A
4
Europe
Lymphapheresis
Assistance Publique - Hôpitaux de Paris
Kidney Transplantation, Liver Transplantation
04/24
04/24
NCT05414292: Impacts of Mechanistic Target of Rapamycin (mTOR) Inhibition on Aged Human Muscle (Rapamune)

Recruiting
N/A
16
Europe
Rapamune (sirolimus) 1Mg Tablet, Rapamycin, Sirolimus, Rapamune, Unilateral resistance exercise training, Leg extension, Strength training
University of Nottingham, University of Oxford
Muscle Atrophy, Age-Related Sarcopenia
05/24
05/24
NCT04562740: ABLUMINUS DES BTK Registry - FIM

Recruiting
N/A
30
RoW
ABLUMINUS DES drug eluting stent
Concept Medical Inc.
Peripheral Artery Disease, Arterial Disease of Legs, Atherosclerosis
06/24
12/24
MAIDEN, NCT04989686: Microsampling Assays for Immunosuppressive Drugs in Children

Recruiting
N/A
150
US
Microsampling
Children's Hospital of Philadelphia, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Immunosuppression
06/25
06/25
NCT05132361: SELUTION4SFA Trial

Recruiting
N/A
300
Europe, US, RoW
SELUTION SLR™ 018 DEB, Plain (Uncoated) Balloon Angioplasty (PTA)
MedAlliance, LLC, NAMSA, Cordis Corporation
Peripheral Arterial Disease, Superficial Femoral Artery Stenosis
12/24
12/29
ChiCTR2100042869: The Efficacy and Safety of Sirolimus Early Conversion Protocol in Liver Transplant Patients with Hepatocellular Carcinoma: a Single-Arm, Multi-Center, Prospective Study

Recruiting
N/A
397
 
Sirolimus
Shulan (Hangzhou) hospital; Shulan (Hangzhou) hospital, self-raised
Hepatocellular carcinoma
 
 
ChiCTR2200056185: Efficacy and safety of oral sirolimus in the treatment of pediatric PIK3CA-Related Overgrowth Spectrum(PROS)

Not yet recruiting
N/A
60
 
oral sirolimus
Beijing Children’s Hospital, Capital Medical University (National Center for Children’s Health, China); Beijing Children’s Hospital, Capital Medical University (National Center for Children’s Health, China), Beijing Natural Science Foundation (No.7222058)
PIK3CA-Related Overgrowth Spectrum(PROS)
 
 
STITCTSC, ChiCTR-OOB-15006535: A Study of mTOR Inhibitor as Adjunctive Therapy in children With Tuberous Sclerosis Complex

Recruiting
N/A
500
 
rapamycin
Chinese PLA General Hospital; Level of the institution:, Beijing Municipal Science & Technology Committee
tuberous sclerosis complex
 
 
ChiCTR2300076085: A Study on the Precision Treatment of Congenital Vascular Malformations and the Establishment of PDX Models Based on PI3K-Akt-mTOR Pathway Gene Abnormalities

Not yet recruiting
N/A
10
 
Gene detection and sirolimus therapy
Fujian Maternal and Child Health Hospital; Fujian Maternal and Child Health Hospital, Fujian Province Science and Technology Innovation Joint Fund Project
Vascular Malformations
 
 
ChiCTR2400085186: Efficacy and safety of sirolimus in patients with relapsed/refractory idiopathic multicenter Castleman disease

Not yet recruiting
N/A
30
 
Sirolimus
Peking Union Medical College Hospital; Peking Union Medical College Hospital, the CAMS Fund for Clinical and Translational Medicine Research Project
According to the Expert Consensus on Diagnosis and Treatment of Castleman Disease in China (2021 Edition), patients diagnosed with iMCD who have undergone at least first-line prior treatment meet the criteria for "relapsed" or "refractory" status.
 
 
NCT05351216: The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma

Recruiting
N/A
174
RoW
Children's Hospital of Fudan University
Kaposiform Hemangioendothelioma
03/26
03/28
NCT05613010: Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant

Recruiting
N/A
50
US
mHealth Messaging Intervention Group
Johns Hopkins University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Transplant;Failure,Kidney, Transplant; Failure, Liver, Adherence, Medication, Adherence, Patient, Adherence, Treatment
03/26
06/26
ChiCTR2400082109: A clinical study on the value of moesin in diagnosing and assessing severity of lymphangioleiomyomatosis

Not yet recruiting
N/A
120
 
sirolimus; nothing; nothing
Zhongshan Hospital, Fudan University; Zhongshan Hospital, Fudan University, Zhongshan Hospital,Fudan University
lymphangioleiomyomatosis
 
 
NCT05746689: Study of Sirolimus in IgG4-related Disease

Not yet recruiting
N/A
20
NA
Sirolimus, Prednisone
Peking University International Hospital
IgG4-related Disease
12/26
12/28
ChiCTR2400082459: Effect of m-TOR pathway gene polymorphisms on the efficacy and safety of Sirolimus in liver transplant patients

Not yet recruiting
N/A
500
 
Non-intervention; Non-intervention
Zhong Shan Hospital, Fudan University; Zhong Shan Hospital, Fudan University, Clinical Research Special Project of Shanghai Municipal Health Commission
Liver transplant
 
 
Prospective clinical study of rapamycin in the treatment of GNBi and GN tumor residues, ChiCTR2300070701: Prospective clinical study on the safety and efficacy of rapamycin in the treatment of unresectable or postoperative residual benign peripheral neuroblastic tumors

Recruiting
N/A
50
 
rapamycin
Beijing Children’s Hospital, Capital Medical University; Beijing Children’s Hospital, Capital Medical University, none
Benign peripheral neuroblastic tumors (including GNBi and GN)
 
 
ChiCTR2400088827: Efficacy and safety of rapamycin combined with roxastat in the treatment of acquired pure red cell aplasia: a prospective, open, randomized, controlled clinical trial

Recruiting
N/A
180
 
Cyclosporine ± glucocorticoid; Rapamycin and roxastat; Rapamycin and roxastat; Rapamycin
Suzhou Hongci Blood Disease Hospital; Suzhou Hongci Blood Disease Hospital, Self-financing
acquired pure red cell aplasia
 
 

Download Options